Tanzania affirms readiness to work with global investors in developing health, science sectors

LONDON: THE Tanzanian government has announced its readiness to collaborate with international investors in developing health and science sectors, to become a hub for pharmaceutical and healthcare product manufacturing in Africa.

Speaking in London on behalf of the Minister for Health, Mohamed Mchengerwa, the Deputy Permanent Secretary responsible for pharmaceuticals and medical devices, Emmanuel Tayari, stated that the government is committed to creating a conducive and enabling environment for investment in pharmaceutical and medical equipment manufacturing.

He noted that these efforts are strongly supported by President Samia Suluhu Hassan, with the government increasingly viewing the health sector not only as a social service but also as a key driver of economic growth. He added that the strategy aims to strengthen local production and reduce reliance on imports, particularly in light of lessons learned during the COVID-19 pandemic.

ALSO READ: Strong cooperation in the health sector firmly cements the Tanzanian union

With a population of over 65 million and access to regional markets through the East African Community (EAC) and the Southern African Development Community (SADC), Tanzania is positioning itself as an attractive destination for investment in healthcare manufacturing, distribution, and innovation.

The government is also developing special investment zones, including Mloganzila and Kibaha, while streamlining regulatory processes through dedicated systems to accelerate strategic investments.

Furthermore, it emphasized the importance of producing high-quality medicines that meet international standards, while maintaining a strict stance against investments involving substandard products or outdated technologies.